key: cord-0796546-bgn24tw4
authors: Kandula, S.; Shaman, J.
title: Association between COVID-19 mortality and population level health and socioeconomic indicators
date: 2021-01-27
journal: nan
DOI: 10.1101/2021.01.25.21250468
sha: ef8af90304100db597569f6b01c7e7885283c671
doc_id: 796546
cord_uid: bgn24tw4

With the availability of multiple COVID-19 vaccines and the predicted shortages in supply for the near future, it is necessary to allocate vaccines in a manner that minimizes severe outcomes. To date, vaccination strategies in the US have focused on individual characteristics such as age and occupation. In this study, we assess the utility of population-level health and socioeconomic indicators as additional criteria for geographical allocation of vaccines. Using spatial autoregressive models, we demonstrate that 43% of the variability in COVID-19 mortality in US counties can be explained by health/socioeconomic factors, adjusting for case rates. Of the indicators considered, prevalence of chronic kidney disease and proportion of population living in nursing homes were found to have the strongest association. In the context of vaccine rollout globally, our findings indicate that national and subnational estimates of burden of disease could be useful for minimizing COVID-19 mortality.

By the end of 2020, the COVID-19 pandemic has resulted in 81.5 million documented cases and 1.8 million deaths globally 23 (1). The United States has contributed nearly a quarter of these cases and has lost 1 in every 1000 residents to COVID-19 24 (2). The outbreak has affected all states in the US but with considerable differences in the trajectory and severity of 25 individual outbreaks. Besides this inter-and intra-state geographical variability, the likelihood of adverse outcomes among 26 those infected is reported to be associated with individual's age, gender, race/ethnicity and underlying health conditions 27 (3-6). An estimated 22% of the global population and 28% of the US have one or more of the underlying conditions that 28 pose increased risk of sever outcomes from COVID-19(7). 29 Early studies on clinical characteristics of severe outcomes from COVID-19 were reported from China(5, 8), after the first 30 large outbreak in Wuhan, and concurring estimates were subsequently published from UK, France, US and elsewhere (3, 4, 31 9-12). Guan et al (8) reported that among 1100 of the earliest laboratory confirmed cases of COVID-19 in China, the 32 presence of co-morbidities such as diabetes, hypertension and chronic obstructive pulmonary disease were more prevalent 33 in those with severe outcomes (admission to ICU, requiring mechanical ventilation or death), along with a slightly elevated 34 risk among men and by now well-established risk with increasing age. Using a larger data sample of 45 thousand cases, 35 Deng et al(5) reported that mortality was associated (relative risk (RR) or hazard ratio (HR)) with cardiovascular disease 36 (RR = 6.75, 95%CI = 5.40-8.43), hypertension (HR = 4.48, 95%CI = 3.69-5.45), diabetes (RR = 4.43, 95%CI = 3.49-5.61) and 37 respiratory disease (RR = 3.43, 95%CI = 2.42-4.87, p < 0.001). 38 A later, more extensive study(9) from the UK linking 17 million cases to 11 thousand deaths also found association between 39 COVID-19 deaths and kidney disease (HR=2.5, 95%CI = 2.3-2.7), diabetes(HR = 1.95, 95%CI = 1.8-2.1), extreme obesity (HR 40 = 1.9, 95%CI = 1.7-2.1) and several other co-morbidities. From a pooled analysis of 75 studies from multiple countries, 41 Popkin et al (12) summarized that individuals with obesity are at increased risk of death (OR = 1.48; 95% CI, 1.22-1.80) 42 hospitalization (OR = 2.13; 95% CI, 1.74-2.60) and ICU admission (OR = 1.74; 95% CI, 1.46-2.08). Based on these findings 43 and the known prevalence of co-morbidities that existed in the population before the emergence of the pandemic, the 44 populations at risk of severe COVID-19 outcomes at county-level in the US(13) and in several countries have been 45 estimated(7). Other studies have examined the associations of socioeconomic characteristics including poverty, income and 46 race/ethnicity (14-16). 47 Over the past year, public health attempts to reduce transmission largely centered on non-pharmaceutical interventions 48 such as social distancing, face coverings and hand hygiene. In the US, these interventions have had limited success and part 49 of this failure stems from their dependence on collective compliance. The recent availability of high efficacy vaccines gives 50 individuals an additional tool to protect themselves (vaccine supply permitting), and importantly, does not require 51 cooperation from collective public. 52 The availability of vaccines also implies an opportunity to refocus our efforts at reducing infections from efforts at reducing 53 severe outcomes by prioritizing vaccination for those at a higher risk of severe outcomes. To date such strategies have been 54 largely guided by individual characteristics such as age and occupation. We hypothesize that population level 55 characteristics can also guide the optimal allocation and distribution of vaccines geographically. This points to a potential 56 two-layered approach of first identifying high-risk communities within which high-risk individuals can be prioritized. 57 Here, we assess the feasibility of the first part of such an approach and evaluate the extent to which the geographical 58 variability of mortality in US can be explained by population characteristics that predate the epidemic. Our outcome of 59 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 27, 2021. ; https://doi.org/10.1101/2021.01.25.21250468 doi: medRxiv preprint 4 interest is COVID-19 associated mortality rates at county resolutions, which we attempt to model as a function of population 60 health and socioeconomic indicators. An initial set of indicators associated with COVID-19 mortality as reported in peer-61 reviewed studies, and data sources for estimates of these indicators were identified. A smaller subset of the variables were 62 selected based on the correlation between the variables and their independent effects on the response. 63 Conventional regression models assume that observations are independent of one another, which in the case of spatial data 64 translates to assuming observations in nearby locations are no more closely related than those farther away. Given the 65 transmission dynamics of COVID-19, counties nearby are likely to be have similar case and death rates and spatial 66 dependence rather than spatial independence is a more appropriate assumption. This spatial dependence also extends to 67 health and socioeconomic indicators and potentially latent and unobservable characteristics that effect mortality. 68 Spatial autoregressive (SAR) models offer a parsimonious way to augment basic regression models with spatial dependence 69 between locations (17), and are an extensively studied family of analytical approaches with applications ranging from 70 econometrics, environmental studies and health sciences (18-20). In the current study, we first establish the presence of 71 spatial autocorrelation in the response and explanatory variables, thus motivating the need for spatial models. We apply 72 three forms of SAR models, show that they explain a greater proportion of the variability in mortality than linear models 73 and report effect estimates from each.

County level indicators of population's health and social status were retrieved from public sources including the US census 76 and large population surveys. In cases where the survey data are not available at county resolutions, data from prior studies 77 on small-area estimates were used. We tried to limit the number of source dependencies and when alternative estimates 78 were available from multiple sources, we preferred estimates from the US Centers for Disease Control and Prevention 79 (CDC). See Table 1 for a list of sources and descriptions for each variable; Figure 1 presents summary statistics. County-specific data for the 5 counties in New York City were retrieved from USAFACTS (24) as the Times' data source was 89 found to combine counts for these five counties into a single entity. Figure 2 shows maps of reported county case and death CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 27, 2021. (Table 1) . 124 Methods overview 125 We first built linear univariate models for each predictor with county-level COVID-19 mortality as outcome, adjusting for 126 county case rates. These models inform both the individual effects and the proportion of variance in mortality explained by 127 each of these predictors. We followed this with a linear multivariate model, again adjusting for case rates. In both univariate 128 and multivariate models, observational independence is inappropriate because of spatial autocorrelation in both the 129 response and predictors. We verify this by standard tests on the residual of the multivariate model. We finally build spatial 130 simultaneous autoregressive models and report effect estimates.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 27, 2021. ; https://doi.org/10.1101/2021.01.25.21250468 doi: medRxiv preprint 6 Spatial weight matrix and spatial autocorrelation 132 As introduced in an earlier section, a key assumption in standard ordinary least square regression (OLS) models is the 133 independence of observations that does not hold because COVID-19 cases and deaths in a county are related to cases and 134 deaths in other counties (spatial dependence) and often counties adjacent to it (spatial autocorrelation). Models that do not 135 account for spatial dependence and autocorrelation are shown to have inflated type I errors (20, 36) . 136 To establish adjacency of counties in the US, we define a simple spatial n x n matrix, W, using shape files that list county 137 boundaries as an ordered set of geocoded reference points (37). County adjacency is defined by queen congruity (at least 138 one shared boundary point) and the spatial weight matrix is row standardized i.e. for each county i, the weight of link to is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 27, 2021. ; https://doi.org/10.1101/2021.01.25.21250468 doi: medRxiv preprint where y is a n x 1 vector of the response variable, X is a n x k matrix of k predictors for n counties, W is the n x n spatial 165 weight matrix, ρ is the spatial autoregressive lag coefficient and λ the spatial error coefficient and β, u the coefficient and 166 error vectors respectively. When λ = 0, the autoregressive process is assumed to occur in the response only (captured by 167 ρW) and the model is referred to as a spatial lag model. When ρ = 0, the autoregressive process is assumed to occur only in 168 the errors (captured by λW), and the model referred to as spatial error model. Model implementations are per spatialreg 169 (43, 45, 46) library in R.

Results from the univariate analysis indicate that the selected variables individually explain 24-29% of the variability in 172 mortality, adjusting for case rates. Mortality is estimated to increase by 43 per thousand residents (95% CI: 37-49) for every 173 1% increase in prevalence of chronic kidney disease, and by 10.4 (95% CI: 8-13) for chronic heart disease, 7.4 (95% CI: 6-174 8) for diabetes, 4.4 (95% CI: 3-5.8) for COPD, 3.7 (95% CI: 2.6-5.8) for high cholesterol, 2.8 (95% CI:2.2-3.3) for high blood 175 pressure and 2.6 (95% CI: 2-3.2) for obesity prevalence respectively ( Figure 5) . These health indicators also explain 28%, 176 25.5%, 27.5%, 24.6%, 24.6%, 25.9% and 25.3% of the variability respectively. 177 Among socioeconomic indicators, the largest association was seen with the nursing home variable (Adjusted R 2 : 29%) with 178 an estimated increase of 39 deaths per thousand (95% CI: 34-44) for every 1% increase in percent living in nursing homes. 179 Mortality rates are estimated to increase by 2.8 (95%CI: 2.3-3.4) and 2.4 (95% CI: 2-2.9) for each 1% increase in percentage 180 of the population who are elderly (65+ years) and uninsured 18-64 year olds, respectively. In contrast, mortality rate is 181 estimated to decrease by 1.5 (95% CI: 1.05-1.87) for every thousand dollar increase in per capita income. On average, the 182 R 2 estimates for socioeconomic indicators are lower than for health indicators. 183 Following variable pruning to correct for collinearity, the multivariate model explained 38% of the variability in mortality 184 with a few changes in effect estimates. Obesity's association is not statistically significant in the presence of kidney disease 185 and COPD's association is counterintuitively negative (Table 2) . 186 Moran's I test for spatial autocorrelation in residuals of the above model was found to be statistically significant (18.4, p < 187 1E-6). Both robust LM tests were found to be significant indicating possible autocorrelation in both the error (28.7, p < 1E-188 6) and response (33.5, p < 1E-6). Hence, three model forms, the general SAR model, spatial lag and spatial error models 189 were attempted. 190 The proportion of variability explained by the SAR models is about 14% higher than the linear model ( Figure 6 ). The spatial 191 error model had an Nagelkerke R 2 (47) of 43.5% with an estimated autocorrelation error coefficient (λ) of .418 (95%CI: .37 192 -.46). The spatial lag model and the general model were observed to have an R 2 nearly identical to that of the error model, 193 The autocorrelation coefficient in response (ρ) was found to be .347 (95%CI: .31-.39) for the spatial model, but when both 194 coefficients were estimated simultaneously in a general model, the lag coefficient was found to be not significant: λ = .336 195 (95%CI: .244-.429); ρ = .083 (95%CI:-.007 -.174; p=.07). Figure 7 shows the spatial lag model's estimates and residuals. 196 The Global Moran's test on the residuals of all three models found no significant spatial autocorrelation (p > .05). Effect 197 estimates for inequality variable were found to be not significant (p > .05) in any of the spatial models ( Figure 6 ). The 198 negative association of COPD seen in the linear model is also observed with the spatial models. Obesity, as in the linear 199 model, was found to be not statistically significant in two of the spatial models.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 27, 2021. ; https://doi.org/10.1101/2021.01.25.21250468 doi: medRxiv preprint 8 To test for sensitivity of models' R 2 to the variable pruning method, we additionally subset variables using alternative 201 spearman correlation thresholds of .5, .65 and .85 and built linear and spatial models with each. Figure 8 shows that R 2 was 202 not sensitive to the value of threshold and the spatial models have a consistently higher R 2 than the linear model. 203 Discussion 204 We have built models to estimate COVID-19 mortality rates for given case rates and population health and socioeconomic 205 characteristics. Our results indicate that together these indicators can explain 43% of the variability in US county mortality 206 rates, when spatial autocorrelation is accounted for. We found that among health indicators considered the prevalence of 207 chronic kidney disease and among socioeconomic indicators the proportion living in nursing homes, have the largest 208 associations with mortality. 209 The choice and timeliness of control strategies in response to an outbreak do affect its progress and caseload. Our findings 210 here show that differential risks of severe outcomes from COVID-19 across populations can be in part estimated from the 211 structures and contexts in which the outbreak occurs, for example, a population's quality of health, its access to healthcare This study has a few limitations. Case and death counts were retrieved a week after the end of the study period. Given the 224 lags in data reporting, particularly with deaths, events occurring at the end of the study period may not have been recorded 225 and the rates used are underestimates. Similarly, the outcomes may not yet be known for cases recorded near the end of 226 the study period. 227 The adjacency based spatial weight matrix that was used in this study does not sufficiently capture the spread of COVID-228 19. Cases that occur in a county are not only correlated with those in counties geographically adjacent to it but also with 229 counties with which it has strong population mixing; for example, counties with metropolitan centers into which 230 commuters travel from the suburbs, or counties with major airports. Spatial weight matrices that capture mobility patterns 231 may be more appropriate and lead to better spatial models. Similarly, methods that can explicitly account for spatial 232 autocorrelation in predictors remain to be explored. 233 Finally, the model structure presented may not be parsimonious in the number of predictors. Although we dropped a third 234 of the predictors initially considered (to correct observed collinearity), model forms with a smaller subset of independent 235 variables may yield near identical R 2 and need to be explored. This is also belied by the lack of significance of some of the 236 predictors included in the spatial models. One approach could start with a minimal set of predictors, incrementally add 237 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 27, 2021. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 27, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 27, 2021. ; https://doi.org/10.1101/2021.01.25.21250468 doi: medRxiv preprint

WHO Coronavirus Disease (COVID-19) Dashboard 2020

United States COVID-19 Cases and Deaths by State over Time

Preliminary estimates of the prevalence of 245 selected underlying health conditions among patients with coronavirus disease 2019-United States

Evidence used to update the list of underlying medical conditions that 248 increase a person's risk of severe illness from COVID-19

Clinical determinants for fatality of 44,672 patients with COVID-19

Coronavirus disease 2019 case 252 surveillance-United States

Global, regional, and national estimates of the 254 population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. The 255 Lancet Global Health

Clinical characteristics of coronavirus disease 2019 in China

Factors associated with COVID-19-related 259 death using OpenSAFELY

Features of 16,749 hospitalised UK patients 261 with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. medrxiv

High prevalence of obesity in severe acute 263 respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Individuals with obesity and COVID-19: A global 265 perspective on the epidemiology and biological relationships

Estimated county-level prevalence of selected 267 underlying medical conditions associated with increased risk for severe COVID-19 illness-United States

Assessment of community-level disparities in 270 coronavirus disease 2019 (COVID-19) infections and deaths in large US metropolitan areas

Impact of COVID-19 outbreak by income: hitting hardest 273 the most deprived

Outcomes of COVID-19: disparities in obesity and by ethnicity/race

Comparing implementations of global and local indicators of spatial association

Local indicators of spatial association-LISA. Geographical analysis

Simple diagnostic tests for spatial dependence. Regional science urban 324 economics

Applied spatial data analysis with R

Team RC. R: A language environment for statistical computing. R Foundation for Statistical Computing: version 3.5. 0

Comparing implementations of estimation methods for spatial econometrics2015: American 329 Statistical Association

Computing the J acobian in G aussian Spatial Autoregressive Models: An Illustrated 331 Comparison of Available Methods

A note on a general definition of the coefficient of determination

Trump administration officials passed when Pfizer offered months ago to sell the 334 U.S. more vaccine doses. The New York Times

Director-General's opening remarks at the media briefing on COVID-19 -8

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted January 27, 2021. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted January 27, 2021. ; https://doi.org/10.1101/2021.01.25.21250468 doi: medRxiv preprint